1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Population-based study of patients with primary Sjögren’s syndrome and lymphoma : lymphoma subtypes, clinical characteristics, and gender differences
(
- Contribution to journal › Article
- 2019
-
Mark
Comparison of patients with and without pre-existing lymphoma at diagnosis of primary Sjögren’s syndrome
(
- Contribution to journal › Article
- 2011
-
Mark
Pediatric organ transplantation and risk of premalignant and malignant tumors in Sweden
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Time trends in risk and risk determinants of non-Hodgkin lymphoma in solid organ transplant recipients
(
- Contribution to journal › Article
-
Mark
Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjogren's syndrome
(
- Contribution to journal › Article
- 2009
-
Mark
Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas:relative risks and time-trends in the Swedish Biologics Register
(
- Contribution to journal › Article
- 2005
-
Mark
Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists
(
- Contribution to journal › Article
-
Mark
Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden
(
- Contribution to journal › Article
-
Mark
Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists
(
- Contribution to journal › Article